31229 — Columbus, Ohio

31229 is a clinical research site located in Columbus, Ohio, United States 43231.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

31229 has participated in 1 clinical trials.

Therapeutic areas: Recurrent Vulvovaginal Candidiasis.

Sponsors: Mycovia Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 31229?

31229 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 31229 conducted?

31229 has 1 clinical trials on record. Their work covers Recurrent Vulvovaginal Candidiasis.

Is 31229 accredited by Crixeo Health?

31229 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 31229?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.